Cartalax 20mg
 
Cartalax is a potent synthetic tripeptide bioregulator that demonstrates significant impact on cellular regeneration and tissue maintenance. This advanced peptide specifically targets fibroblast function, promoting enhanced skin health, connective tissue integrity, and joint support. Research indicates Cartalax effectively modulates cellular proliferation while reducing age-related degenerative processes, making it a leading choice for anti-aging and regenerative applications.
 
Premium Grade - 99%+ Purity - Laboratory Tested
 
Product Overview
Cartalax represents cutting-edge peptide technology in the bioregulator category. As a three-amino acid sequence (Alanine-Glutamic Acid-Aspartic Acid), this peptide demonstrates remarkable specificity for connective tissues throughout the body. Studies show consistent benefits in cellular renewal, extracellular matrix stabilization, and inflammatory response modulation.
 
Technical Specifications
 
Amino Acid Sequence: Ala-Glu-Asp (AED)
Molecular Formula: C₁₂H₁₉N₃O₈
Molecular Weight: 333.29 g/mol
Purity: >99% (HPLC verified)
Appearance: White lyophilized powder
Storage: -20°C (long-term), 2-8°C (short-term)
Stability: 24 months when properly stored
 
Mechanisms of Action
 
Fibroblast Regulation and Skin Health
Cartalax demonstrates profound effects on skin fibroblasts, the primary cells responsible for collagen synthesis and extracellular matrix maintenance. Research shows this peptide significantly increases Ki-67 expression (a key proliferation marker) while simultaneously reducing apoptotic processes through caspase pathway inhibition.
The peptide effectively modulates matrix metalloproteinase-9 (MMP-9) synthesis, which typically increases during cellular aging. By balancing MMP activity, Cartalax helps maintain optimal tissue remodeling without excessive matrix degradation.
 
Cartilage and Joint Support
 
While direct cartilage studies are limited, extensive fibroblast research strongly suggests significant benefits for joint health. Fibroblasts serve as primary regulators of cartilage homeostasis, and Cartalax influences multiple pathways crucial for joint integrity
AP-1 and NF-κB signaling optimization
TGF-β and TNF-α balance
MMP-1, MMP-3, and MMP-8 regulation
Collagen synthesis enhancement
These mechanisms position Cartalax as particularly valuable for individuals experiencing age-related joint changes, athletic stress, or cartilage maintenance needs.
 
Anti-Aging Properties
 
Cartalax demonstrates significant geroprotective effects by influencing key aging-related gene expression patterns. Studies show dramatic changes in critical aging markers, with expression modifications ranging from 1.6- to 5.6-fold:
IGF-1 upregulation (growth and repair)
SIRT-6 enhancement (genomic stability)
p53, p16, and p21 reduction (senescence markers)
TERT activation (telomerase function)
 
Renal Health Benefits
 
Early research identified Cartalax in kidney-derived polypeptide extracts that demonstrated remarkable cell renewal properties. Subsequent studies confirm the peptide's ability to increase renal cell proliferation while reducing pro-apoptotic signaling.
Research Applications
Primary Research Areas:
Skin aging and regeneration studies
Cartilage repair and maintenance research
Anti-aging and longevity investigations
Fibroblast function optimization
Extracellular matrix research
Experimental Protocols:
Most research protocols utilize 5-10mg daily dosing via subcutaneous administration. Cycle lengths typically range from 20-30 days with 4-6 month intervals between courses. Research subjects often report initial effects within 2-3 weeks, with continued benefits throughout the protocol
Quality Assurance
PeptidesAlpha maintains the highest quality standards for all bioregulator peptides:
✓ 99%+ Purity verified by HPLC/MS analysis
✓ Pharmaceutical-grade synthesis protocols
✓ Sterile manufacturing environment
✓ Comprehensive Certificate of Analysis provided
✓ Third-party testing for purity and potency
✓ Proper cold-chain storage and shipping
Legal Notice
FOR RESEARCH PURPOSES ONLY - NOT FOR HUMAN CONSUMPTION
This product is intended exclusively for laboratory research and analytical applications. Cartalax has not been approved by the FDA for human therapeutic use. This peptide is classified as a research chemical and should only be handled by qualified researchers in appropriate laboratory settings.
PeptidesAlpha products are furnished for in-vitro studies only and are not intended to diagnose, treat, cure, or prevent any medical condition. Bodily introduction into humans or animals is strictly prohibited by law.